These results strongly support 46 as a prototypical lead for the development of promising CXCR4 antagonists as clinical candidates.Ferric nitrosyl (FeNO6) and ferrous nitrosyl (FeNO7) complexes of the chlorite dismutases (Cld) from Klebsiella pneumoniae and Dechloromonas aromatica have been characterized using UV-visible absorbance and Soret-excited resonance Raman spectroscopy. Both of these Clds form kinetically stable FeNO6 complexes and they occupy a unique region of ν(Fe-NO)/ν(N-O) correlation space for proximal histidine liganded heme proteins, characteristic of weak Fe-NO and N-O bonds. This location is attributed to admixed FeIII-NO character of the FeNO6 ground state. Cld FeNO6 complexes undergo slow reductive nitrosylation to yield FeNO7 complexes. The effects of proximal and distal environment on reductive nitroylsation rates for these dimeric and pentameric Clds are reported. The ν(Fe-NO) and ν(N-O) frequencies for Cld FeNO7 complexes reveal both six-coordinate (6c) and five-coordinate (5c) nitrosyl hemes. These 6c and 5c forms are in a pH dependent equilibrium. The 6c and 5c FeNO7 Cld frequencies provided positions of both Clds on their respective ν(Fe-NO) vs ν(N-O) correlation lines. The 6c FeNO7 complexes fall below (along the ν(Fe-NO) axis) the correlation line that reports hydrogen-bond donation to NNO, which is consistent with a relatively weak Fe-NO bond. Kinetic and spectroscopic evidence is consistent with the 5c FeNO7 Clds having NO coordinated on the proximal side of the heme, analogous to 5c FeNO7 hemes in proteins known to have NO sensing functions.The effect of self-doping Ti3+ into V2O5/TiO2 catalysts on the activity of the catalysts was assessed by the selective catalytic reduction of NOX with NH3 (NH3-SCR). 0.2-V2O5/TiO2 (Al(acac)3TBOT = 0.2%) catalyst had the highest catalytic activity at low-temperature range. The as-prepared catalysts are characterized by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), electron paramagnetic resonance (EPR), H2 temperature-programmed reduction (H2-TPR), NH3 temperature-programmed desorption (NH3-TPD), surface area and pore structure. XPS and EPR were used to confirm the existence of Ti3+ and oxygen vacancy in the catalysts. The specific surface area, surface acidity, reducibility and valence state of the active components of the catalysts are significantly affected by the self-doping of Ti3+. This work would lead to a new strategic design of Ti3+ self-doped catalysts with fine structure and that can efficiently improve low-temperature SCR performance.Controlling the morphology and structure of nanomaterials is of great importance for enhancing the electrochemical properties. In the paper, Mn3O4-Fe3O4@C hybrids with different architectures were synthesized by incubation of electrospun FeOx-containing carbon fiber (Fe-CNF) in KMnO4 solution followed by annealing. The presence of FeOx on the CNF plays a vital role in determining the morphology and structure of the final hybrids, and the Mn3O4-Fe3O4@C hybrids with half-tube, tube and oolite-filled fibers are formed conveniently by tuning Fe content in the carbon fiber precursor. The good conductivity of fiber and various redox states of Mn and Fe afford the facile charge transfer and excellent reversible redox properties, thus enhancing the capacitor performance. The oolite-filled Mn3O4-Fe3O4@C with tubular structure exhibited a high specific capacitance of 178 F g-1 at a discharge rate of 1 A g-1. This capacitor electrode has an excellent cyclic stability with 95% capacitance retention after 1000 cycles at 3 A g-1. This work provides a very simple strategy to tune the unique nanostructures of metal oxide on Fe-CNF for high-performance supercapacitor application in the future.Nickel sulfide possesses ultra-high theoretical energy storage capacity. Though it is easily obtained, it is very difficult to exert its intrinsic strong capacity. In this work, a new strategy based on a binary synergy of sulfur sources is introduced. By regulating the molar ratio of two sulfur sources, a high-performance α-NiS/Ni3S4 binary hybrid is successfully synthesized. Interestingly, it is found that changing the molar ratio of two sulfur sources in hydrothermal process can efficiently regulate the components of product but cannot visibly affect its morphology. The electrochemical results indicate that this strategy is highly effective for improving the performance of nickel sulfide. As a result, a highest specific capacity of 214.9 mAh g-1 at 2 A g-1 was reached. In addition, the fabricated S3//rGO hybrid supercapacitor displays a highest energy density of 41.9 Wh kg-1 at a power density of 799.0 kW kg-1. Moreover, the device delivers an excellent cycle stability with 103% capacity retention rate after 10,000 cycles. https://www.selleckchem.com/products/way-100635.html These findings open a new avenue for the controlled synthesis of high-performance nickel sulfides or other metal sulfides.The use of nanoscale metal-organic frameworks (MOFs) as drug delivery vehicles has attracted considerable attention in tumor therapy. In this study, novel biocompatible MOF-based nanocarriers were used as part of a facile and reproducible strategy for precision cancer theranostics. Both diagnostic (Mn2+) and therapeutic compounds (doxorubicin, DOX) were incorporated into the multifunctional MOF-based nanocarriers, which exhibited high colloidal stability and promoted T1-weighted proton relaxivity and low-pH-activated drug release. The obtained MOF-based nanocarriers exhibited significantly high cellular uptake and efficient intracellular drug delivery into cancer cells, which resulted in high apoptosis and cytotoxicity, in addition to effectively inhibiting the migration of 4T1 breast cancer cells. Moreover, the MOF-based nanocarriers could intensively deliver diagnostic and therapeutic agents to tumors to enable precise visualization of the nanocarrier accumulation and accurate tumor positioning, diagnosis, and imaging-guided therapy using magnetic resonance imaging (MRI). In addition, the functional MOF-based nanocarriers exhibited effective ablation of the primary breast cancer, as well as significant inhibition of lung metastasis with a high survival rate. Therefore, the developed nanocarriers represent a viable platform for cancer theranostics.